Compare RBLX & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBLX | GEHC |
|---|---|---|
| Founded | 2006 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8B | 35.8B |
| IPO Year | 2020 | 2022 |
| Metric | RBLX | GEHC |
|---|---|---|
| Price | $68.34 | $84.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 12 |
| Target Price | ★ $121.77 | $91.17 |
| AVG Volume (30 Days) | ★ 11.9M | 3.2M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | $2,225,052,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $70.92 | $7.15 |
| Revenue Next Year | $16.76 | $4.53 |
| P/E Ratio | ★ N/A | $18.47 |
| Revenue Growth | ★ 15.94 | 4.84 |
| 52 Week Low | $50.10 | $57.65 |
| 52 Week High | $150.59 | $92.20 |
| Indicator | RBLX | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 57.27 |
| Support Level | $60.12 | $81.84 |
| Resistance Level | $75.41 | $85.87 |
| Average True Range (ATR) | 4.35 | 2.26 |
| MACD | 0.63 | 0.51 |
| Stochastic Oscillator | 40.76 | 78.63 |
Roblox operates a free-to-play online video game platform with nearly 150 million daily active users. This platform has spawned a virtual universe and a Roblox economy based on the Robux currency. The platform houses millions of games from a wide range of creators—spanning from young gamers themselves to professional development studios. Roblox offers creators the tools, publishing abilities, and platform for their games, enabling anyone to create a game. Creators earn money when gamers make optional in-game purchases within their games and by offering space for real-world advertising, and Roblox earns revenue primarily by taking a cut of these earnings.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).